发明名称 |
ErbB-2 receptor targeting peptide |
摘要 |
The ErbB-2 receptor, a member of the tyrosine kinase type 1 family of receptors, has been implicated in many human malignancies. Bacteriophage display technology was employed to identify peptides that bound to the extracellular domain of human ErbB-2. The peptide KCCYSL, most frequently occurring in the affinity selected population, was chemically synthesized and characterized for its binding activities to the recombinant extracellular domain of ErbB-2. The synthetic peptide exhibits high specificity to ErbB-2 as well as to ErbB-1, another member of ErbB family. Thus, this peptide can be employed in cancer imaging or therapeutic agent targeting to malignant cells ErbB-2 receptor. |
申请公布号 |
US9061054(B2) |
申请公布日期 |
2015.06.23 |
申请号 |
US200912555375 |
申请日期 |
2009.09.08 |
申请人 |
The Curators of The University of Missouri |
发明人 |
Quinn Thomas P.;Karasseva Natalia G. |
分类号 |
A61K49/00;G01N33/574;G01N33/74;A61K49/10;A61K33/24;A61B5/00;A61K51/08;A61K38/08 |
主分类号 |
A61K49/00 |
代理机构 |
Norton Rose Fulbright US LLP |
代理人 |
Norton Rose Fulbright US LLP |
主权项 |
1. A method for diagnosing ErbB-2-positive cancer in a subject comprising:
(a) administering to said subject a peptide-diagnostic agent complex, wherein said peptide is between 6 and about 100 residues in length and comprises the sequence KCCYSL (SEQ ID NO: 1) and wherein the peptide binds to ErbB-2; and (b) assessing the amount and/or localization in said subject, of the diagnostic agent. |
地址 |
Columbia MO US |